KORU MEDICAL SYSTEMS INC (KRMD) Stock Price, Quote, News and Overview
NASDAQ:KRMD - Nasdaq - US7599101026 - Common Stock - Currency: USD
KRMD Quote, Performance and Key Statistics
3.48
+0.02 (+0.58%)
The current stock price of KRMD is 3.48 USD. In the past month the price decreased by -3.87%. In the past year, price increased by 51.97%.
KRMD Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 25.98 | 221.46B | ||
| ISRG | INTUITIVE SURGICAL INC | 60.01 | 173.19B | ||
| BSX | BOSTON SCIENTIFIC CORP | 37.25 | 155.95B | ||
| SYK | STRYKER CORP | 29.4 | 144.38B | ||
| MDT | MEDTRONIC PLC | 16.24 | 114.47B | ||
| BDX | BECTON DICKINSON AND CO | 12.52 | 50.55B | ||
| EW | EDWARDS LIFESCIENCES CORP | 30.87 | 46.53B | ||
| IDXX | IDEXX LABORATORIES INC | 46.98 | 43.07B | ||
| RMD | RESMED INC | 29.24 | 40.94B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 14.99 | 31.98B | ||
| DXCM | DEXCOM INC | 46.64 | 31.09B | ||
| PHG | KONINKLIJKE PHILIPS NVR- NY | 16.04 | 25.48B |
Related stock screener links
About KRMD
Company Profile
KORU Medical Systems, Inc. engages in the design, manufacture, and market of proprietary medical devices. The company is headquartered in Mahwah, New Jersey and currently employs 80 full-time employees. The firm is focused on developing, manufacturing, and commercializing patient-centric large volume subcutaneous infusion solutions primarily for the subcutaneous drug delivery market. The firm is focused on its mechanical infusion products, the FREEDOM Infusion Systems (FREEDOM System), which include the FREEDOM60 Syringe Driver, the FreedomEdge Syringe Driver, HIgH-Flo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing. The Company’s infusion devices work together as a system to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases (PIDD) and chronic inflammatory demyelinating polyneuropathy (CIDP). The FREEDOM System operates at a lower pressure than an electrical, volumetric pump and maintains a balance between what a patient’s subcutaneous tissues can tolerate and what the system delivers.
Company Info
KORU MEDICAL SYSTEMS INC
100 Corporate Drive
Mahwah NEW JERSEY 10918 US
CEO: James M. Beck
Employees: 80
Phone: 18454692042
KORU MEDICAL SYSTEMS INC / KRMD FAQ
What is the stock price of KORU MEDICAL SYSTEMS INC today?
The current stock price of KRMD is 3.48 USD. The price increased by 0.58% in the last trading session.
What is the ticker symbol for KORU MEDICAL SYSTEMS INC stock?
The exchange symbol of KORU MEDICAL SYSTEMS INC is KRMD and it is listed on the Nasdaq exchange.
On which exchange is KRMD stock listed?
KRMD stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for KORU MEDICAL SYSTEMS INC stock?
11 analysts have analysed KRMD and the average price target is 5.61 USD. This implies a price increase of 61.21% is expected in the next year compared to the current price of 3.48. Check the KORU MEDICAL SYSTEMS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is KORU MEDICAL SYSTEMS INC worth?
KORU MEDICAL SYSTEMS INC (KRMD) has a market capitalization of 160.57M USD. This makes KRMD a Micro Cap stock.
How many employees does KORU MEDICAL SYSTEMS INC have?
KORU MEDICAL SYSTEMS INC (KRMD) currently has 80 employees.
What are the support and resistance levels for KORU MEDICAL SYSTEMS INC (KRMD) stock?
KORU MEDICAL SYSTEMS INC (KRMD) has a support level at 3.4 and a resistance level at 3.61. Check the full technical report for a detailed analysis of KRMD support and resistance levels.
Is KORU MEDICAL SYSTEMS INC (KRMD) expected to grow?
The Revenue of KORU MEDICAL SYSTEMS INC (KRMD) is expected to grow by 15.67% in the next year. Check the estimates tab for more information on the KRMD EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy KORU MEDICAL SYSTEMS INC (KRMD) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of KRMD, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of KRMD, evaluating the profitability, health, valuation and growth aspects
- KORU MEDICAL SYSTEMS INC (KRMD) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- KORU MEDICAL SYSTEMS INC (KRMD) Sales and EPS estimates to see what analysts future expectations are.
- KORU MEDICAL SYSTEMS INC (KRMD) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- KORU MEDICAL SYSTEMS INC (KRMD) Insider and Institutional Ownership to learn about the owners and their transactions.
- KORU MEDICAL SYSTEMS INC (KRMD) Stock Chart to make your own analysis
- KORU MEDICAL SYSTEMS INC (KRMD) Latest news and press-releases to stay up to date.
Does KORU MEDICAL SYSTEMS INC (KRMD) stock pay dividends?
KRMD does not pay a dividend.
When does KORU MEDICAL SYSTEMS INC (KRMD) report earnings?
KORU MEDICAL SYSTEMS INC (KRMD) will report earnings on 2025-08-06, after the market close.
What is the Price/Earnings (PE) ratio of KORU MEDICAL SYSTEMS INC (KRMD)?
KORU MEDICAL SYSTEMS INC (KRMD) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.1).
What is the Short Interest ratio of KORU MEDICAL SYSTEMS INC (KRMD) stock?
The outstanding short interest for KORU MEDICAL SYSTEMS INC (KRMD) is 3.2% of its float. Check the ownership tab for more information on the KRMD short interest.
KRMD Technical Analysis
ChartMill assigns a technical rating of 7 / 10 to KRMD. When comparing the yearly performance of all stocks, KRMD is one of the better performing stocks in the market, outperforming 89.82% of all stocks.
KRMD Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to KRMD. KRMD scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
KRMD Financial Highlights
Over the last trailing twelve months KRMD reported a non-GAAP Earnings per Share(EPS) of -0.1. The EPS increased by 23.08% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -19.46% | ||
| ROE | -32.41% | ||
| Debt/Equity | 0.02 |
KRMD Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 80% to KRMD. The Buy consensus is the average rating of analysts ratings from 11 analysts.
For the next year, analysts expect an EPS growth of 20.95% and a revenue growth 15.67% for KRMD